All posts by: Michael Zand

About Michael Zand

European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing – PR Newswire (press release)

Continue reading

2017-06-23 NEWS

European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing
PR Newswire (press release)
Our approach is to use our CRISPR/Cas9 gene editing tool to re-create the small changes to the DNA that cause “Hereditary Persistence of Fetal Hemoglobin” and lead to expression of the protective fetal hemoglobin to reduce symptoms in patients with …

and more »

Continue reading

2017-06-23 NEWS

European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing
PR Newswire (press release)
Our approach is to use our CRISPR/Cas9 gene editing tool to re-create the small changes to the DNA that cause “Hereditary Persistence of Fetal Hemoglobin” and lead to expression of the protective fetal hemoglobin to reduce symptoms in patients with …

and more »

Continue reading

2017-06-23 NEWS

Q13 FOX

Power of immunotherapy saves local man’s life
Q13 FOX
SEATTLE — Far away from the buzz of city noise, along the open road in Fall City, a cyclist finds solace. “I think about what it feels like — the wind in my face, the sound. I feel how lucky I am to have gotten to this place.” It’s here, peppered